User Comments Most Liked Latest
Login to join the conversation.
Reddit Mentions Today Week Month
I focus on it differently, so I rather prefer comment it: Main (70-80%): GOOGL, META, AMZN, MSFT, ASML, RMS, 2330, MA Extremely high quality (15-25%): V, ITX, MONC, RACE, BKNG, BRK B, My personal bets for many reasons (5-15%): CHKP, UTHR, EVO, MRK, ADYEN, GAW, ZETA Special situations and even …
MA, AXP, BRKB, RTX, UNH, CNC, ALL, BLK, BA, LMT, BP, CAT, BROS, DIS, IBM, MRK, LLY, NFLX, PLD, WELL,and WRB. List goes on, boring and consistent for the majority.
Parallel/Analogue of Dot Com bubble, fed rat cuts, melting up, and thesis for big pharma and managed care (didn't happen, I ran out of space). For those who lack reading comprehension, I’m saying that the market will melt up, not crash immediately. Before I start, I just want to acknowledge …
I did the same thing with gild . I bought during covid at 70$ its currently at 126$ . I sold during may when it dipped down from 112$ to 102$. Also had CMI average of 240$ sold at 338$ because ot wasn’t recovering as fast as my other stocks …
Can someone explain why this sub is obsessed with NVO, other than anchoring to prior price points, because it’s not like it’s the only discounted big pharma play. PFE, BMY, MRK, SNY, GSK, and I’m sure more are all major brand players and comparably cheap.
Most Asymmetric Opportunity in Biotech (and the whole market?) $GANX **It’s not often that an investment opportunity comes along with the asymmetric upside and limited downside that GANX has IMO, and in such a short timeline**. The problem is that most investors can’t take a casual glance at the company …
Glad I bought MRK instead of Pfizer.
$PFE, $BMY, $MRK, you know the drill.....
I just don't know why people force themselves to buy NOVO. It is cheap for a reason. Classic value trap IMO. Look at MRK, REGN, etc. and what they've done lately. Great runs. This tells you it's not a sector problem- it's an individual company problem. LLY is up 34% …
MRK spent 20Y to make an ATH. I used to own the stock but somehow I’m numb seeing it climbing up recently. Congrats on LLY btw, im still holding my Mariana trenchonovo
I did not expect MRK to give tech stock level returns.
I bought LLY in 2019 (<$200), sold it (\~$900) last year, and used the money to swap to NVO, MRK, PFE, BMY. In Sept I added some LLY back (\~$700). I added more NVO today and expect to add more as tax loss harvesting pushes it further down. I have …
Not sure why I started a position in NVO honestly. MRK and REGN both have obesity drug pipelines and traded cheaper. REGN not anymore. MRK still cheap. Both of these positions are up massively.
I got into NVO over the summer after a very successful investment in VRNA. I started reading more about them and found they lost patent protection in Canada for the weight loss drug due to negligence, and that drug "compounders" were rapidly stealing market share from them. Those two facts …
Apparently the OP thinks a value pick is buying the absolute bottom. I think its fine if you are willing to ride out volatility. Chart looks like MRK 2.0, which is doing quite well now. I added premarket on the gap down. My price alert is set for 39s so …
I like MRK. Doesn’t get much discussion. The $80-$85 range was a good buying zone recently. They’ve had some good sentiment lately. It’s a solid long term buy to me.
The trend has changed for Big Pharma - the market is getting more defensive Health care has been underperforming - its been [the worst performing sector in the last 5 years.](https://userupload.gurufocus.com/1992615725424091136.png) However the trend is now changing. Below is a table of the top-10 big Pharma Co's giving total return …
Oh man you have all the speculative tickers. I held all of these at one time or another but sold weeks ago. Im in blue chip Healthcare stonks rn. Only sector that's going up. Trying to get into $MRK but it keeps mooning. Won't hit my limit.
some good non-AI stocks already look cheap I’ve been checking Return on Risk + a quick Reverse DCF, and UNH, TRV, CRM and even MRK look surprisingly cheap right now. (I use FindGreatStocks(dot)com for this, but you can do it manually too.)”
Good few weeks to be a MRK bag holder
KMB MRK. REITS as well. I like some of your defensive picks. I’m looking for more defensive stocks, reasonable growth, with dividends.
WMT, RSG, and WM are all great, stable businesses. But all 3 of them are horrendously overvalued right now which could seriously limit any potential upside if you're buying at their current share prices. PGR might have some modest undervaluation. I'd say MO is finally trading around fair price, not …
Related News
No related news found for this ticker.
Badges / Notes
- No notable badges.
Total Off-Exchange Volume: 4.7 million
Values over 50% Short often indicate hidden bearish pressure from institutions.
🏆 Master Buzz Score: 2/15
Capitol Trades
| Date | Politician | Amount |
|---|---|---|
| No recent trades found. | ||
Insider Trades
| Date | Insider | Value |
|---|---|---|
| No recent trades found. | ||
Institutional Holdings (Whales)
| Institution | Shares | Value | % Held | Date |
|---|---|---|---|---|
| Vanguard Group Inc | 252,136,910 | $26.4 billion | 0.1016% | Sep 30, 2025 |
| Blackrock Inc. | 214,876,600 | $22.5 billion | 0.0866% | Sep 30, 2025 |
| State Street Corporation | 118,180,178 | $12.4 billion | 0.0476% | Sep 30, 2025 |
| Wellington Management Group, LLP | 75,279,104 | $7.9 billion | 0.0303% | Sep 30, 2025 |
| JPMORGAN CHASE & CO | 70,403,294 | $7.4 billion | 0.0284% | Sep 30, 2025 |
| Geode Capital Management, LLC | 59,798,874 | $6.3 billion | 0.0241% | Sep 30, 2025 |
| Charles Schwab Investment Management, Inc. | 53,699,460 | $5.6 billion | 0.0216% | Sep 30, 2025 |
| Morgan Stanley | 44,586,535 | $4.7 billion | 0.0180% | Sep 30, 2025 |
| NORGES BANK | 36,111,289 | $3.8 billion | 0.0145% | Jun 30, 2025 |
| FMR, LLC | 33,426,750 | $3.5 billion | 0.0135% | Sep 30, 2025 |

No comments yet. Be the first!